DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/h96n4m/liver_cancer) has announced the addition of the "Liver Cancer - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Cancer and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Liver Cancer Overview
- Therapeutics Development
- Pipeline Products for Liver Cancer- Overview
- Pipeline Products for Liver Cancer- Comparative Analysis
- Liver Cancer- Therapeutics under Development by Companies
- Liver Cancer- Therapeutics under Investigation by Universities/Institutes
- Liver Cancer- Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Liver Cancer- Products under Development by Companies
- Liver Cancer- Products under Investigation by Universities/Institutes
- Liver Cancer- Companies Involved in Therapeutics Development
Companies Mentioned - Sample List
- 4SC AG
- AB Science SA
- AbbVie Inc.
- Acceleron Pharma, Inc.
- ACROVIS Pharma AG
- Adaptimmune Limited
- Aduro BioTech, Inc.
- Advanced Accelerator Applications SA
- Advenchen Laboratories, LLC
- Alfact Innovation
- Alnylam Pharmaceuticals, Inc.
- American Gene Technologies International Inc.
- Amgen Inc.
- AndroScience Corporation
- APAvadis Biotechnologies Srl
- Arbutus Biopharma Corporation
- ArQule, Inc.
- Array BioPharma Inc.
- Arrowhead Research Corporation
- Astex Pharmaceuticals, Inc.
- AstraZeneca Plc
- AVEO Pharmaceuticals, Inc.
- Bayer AG
- Bio-Cancer Treatment International Limited
- BioCancell Ltd
- Biogazelle
- Bioneer Corporation
- BioStar Pharmaceuticals, Inc.
- Blueprint Medicines
- Boehringer Ingelheim GmbH
- Boston Biomedical, Inc.
- Bristol-Myers Squibb Company
- Caladrius Biosciences, Inc.
- Can-Fite BioPharma Ltd.
- CASI Pharmaceuticals Inc.
For more information visit http://www.researchandmarkets.com/research/h96n4m/liver_cancer
